Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

BACKGROUND: Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy. However, limited data exist on the utility of cytoreductive...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Surg Oncol
Main Authors: Leigh, Natasha, Solomon, Daniel, Pletcher, Eric, Labow, Daniel M., Magge, Deepa R., Sarpel, Umut, Golas, Benjamin J.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7291534/
https://ncbi.nlm.nih.gov/pubmed/32527272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01898-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki